- Home
- STRO vs EOT Comparison
STRO vs EOT Comparison
Compare STRO & EOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- EOT
- Stock Information
- Founded
- STRO 2003
- EOT 2009
- Country
- STRO United States
- EOT United States
- Employees
- STRO N/A
- EOT N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- EOT Investment Bankers/Brokers/Service
- Sector
- STRO Health Care
- EOT Finance
- Exchange
- STRO Nasdaq
- EOT Nasdaq
- Market Cap
- STRO 292.6M
- EOT 273.1M
- IPO Year
- STRO 2018
- EOT N/A
- Fundamental
- Price
- STRO $2.89
- EOT $17.40
- Analyst Decision
- STRO Strong Buy
- EOT
- Analyst Count
- STRO 7
- EOT 0
- Target Price
- STRO $12.14
- EOT N/A
- AVG Volume (30 Days)
- STRO 596.9K
- EOT 38.7K
- Earning Date
- STRO 11-13-2024
- EOT 01-01-0001
- Dividend Yield
- STRO N/A
- EOT 4.51%
- EPS Growth
- STRO N/A
- EOT N/A
- EPS
- STRO N/A
- EOT N/A
- Revenue
- STRO $160,955,000.00
- EOT N/A
- Revenue This Year
- STRO N/A
- EOT N/A
- Revenue Next Year
- STRO N/A
- EOT N/A
- P/E Ratio
- STRO N/A
- EOT N/A
- Revenue Growth
- STRO 230.90
- EOT N/A
- 52 Week Low
- STRO $2.13
- EOT $14.63
- 52 Week High
- STRO $6.13
- EOT $18.30
- Technical
- Relative Strength Index (RSI)
- STRO 32.85
- EOT 38.44
- Support Level
- STRO $4.01
- EOT $17.36
- Resistance Level
- STRO $4.60
- EOT $17.54
- Average True Range (ATR)
- STRO 0.36
- EOT 0.15
- MACD
- STRO -0.06
- EOT -0.02
- Stochastic Oscillator
- STRO 3.93
- EOT 12.86
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
About EOT Eaton Vance Municipal Income Trust EATON VANCE NATIONAL MUNICIPAL OPPORTUNITIES TRUST
Eaton Vance National Municipal Opportunities Trust is a diversified, closed-end management investment company. The company's investment objective is to provide current income exempt from regular federal income tax and to achieve capital appreciation. It invests a majority of its assets in debt obligations issued by or on behalf of states, territories, and possessions of the United States, including the District of Columbia, and their political subdivisions, agencies, or instrumentalities, the interest on which is exempt from regular federal income tax.